REQUEST A DEMO
Total
USD $0.00
Search more companies

OU PharmaSeventeen (Estonia)

Main Activities: Pharmacies and Drug Stores
Full name: OU PharmaSeventeen Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

OU PharmaSeventeen is based in Estonia, with the head office in Tallinn. The company operates in the Pharmacies and Drug Stores industry. The company was established on June 11, 2020. It currently has a total number of 4 (2024) employees. There was a net sales revenue increase of 26.27% reported in OU PharmaSeventeen’s latest financial highlights for 2024. There was a total negative growth of 9.36% in OU PharmaSeventeen’s total assets over the same period. The net profit margin of OU PharmaSeventeen increased by 0.42% in 2024.

Headquarters
Akadeemia tee 45 Mustamae linnaosa
Tallinn; Harju county; Postal Code: 13520

Contact Details: Purchase the OU PharmaSeventeen report to view the information.

Basic Information
Total Employees:
Purchase the OU PharmaSeventeen report to view the information.
Registered Capital:
Purchase the OU PharmaSeventeen report to view the information.
Financial Auditors:
Purchase the OU PharmaSeventeen report to view the information.
Incorporation Date:
June 11, 2020
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after OU PharmaSeventeen report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
26.27%
Total operating revenue
26.27%
Operating profit (EBIT)
1389.56%
EBITDA
1121.1%
Net Profit (Loss) for the Period
1382.36%
Total assets
-9.36%
Total equity
26.13%
Operating Profit Margin (ROS)
0.42%
Net Profit Margin
0.42%
Return on Equity (ROE)
-33.61%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?